Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer
Matthew L. Hedberg(Carnegie Mellon University), Jennifer R. Grandis(University of California, San Francisco)
Cited by 57
Related Papers
Head and neck squamous cell carcinoma
|Nature Reviews Disease Primers|2020|4k
Characterization of HPV and host genome interactions in primary head and neck cancers
|Proceedings of the National Academy of Sciences|2014|397
Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer
|Nature Genetics|2016|252
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
|Journal of Clinical Investigation|2015|200